| 2017-02 | Development of novel cilostazol-loaded solid SNEDDS using a SPG membrane emulsification technique: Physicochemical characterization and in vivo evaluation | 최한곤 |
| 2009-05 | Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution | 최한곤 |
| 2016-07 | Development of novel prasugrel base microsphere-loaded tablet with enhanced stability: Physicochemical characterization and in vivo evaluation in beagle dogs | 최한곤 |
| 2023-10 | Development of Novel Tamsulosin Pellet-Loaded Oral Disintegrating Tablet Bioequivalent to Commercial Capsule in Beagle Dogs Using Microcrystalline Cellulose and Mannitol | 최한곤 |
| 2020-01 | Development of novel tenofovir disoproxil phosphate salt with stability enhancement and bioequivalence to the commercial tenofovir disoproxil fumarate salt in rats and beagle dogs | 최한곤 |
| 2020-06 | Development of Noveld-Cycloserine Tablet with Improvement of Drug Stability and Dissolution-Equivalence to thed-Cycloserine-Loaded Commercial Hard Capsule | 최한곤 |
| 2000-09 | Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva | 최한곤 |
| 2016-08 | Development of polymeric irinotecan nanoparticles using a novel lactone preservation strategy | 최한곤 |
| 2008-07 | Development of polyvinyl alcohol-sodium alginate gel-matrix-based wound dressing system containing nitrofurazone | 최한곤 |
| 2021-05 | Development of rebamipide-loaded spray-dried microsphere using distilled water and meglumine: physicochemical characterization and pharmacokinetics in rats | 최한곤 |
| 2017-01 | Development of RP-HPLC method for simultaneous determination of docetaxel and curcumin in rat plasma: Validation and stability | 최한곤 |
| 2016-04 | Development of Solid Self-Emulsifying Formulation for Improving the Oral Bioavailability of Erlotinib | 최한곤 |
| 2000-06 | Development of terfenadine-pseudoephedrine double-layer tablet dissolution-equivalent to core tablet | 최한곤 |
| 2020-08 | Diagnostic and Treatment Strategies for COVID-19 | 최한곤 |
| 2017-02 | Doxorubicin and paclitaxel co-bound lactosylated albumin nanoparticles having targetability to hepatocellular carcinoma | 최한곤 |
| 2016-08 | Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer | 최한곤 |
| 2016-03 | Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors | 최한곤 |
| 2004-06 | Dual inhibition of cyclooxygenases-2 and 5-lipoxygenase by deoxypodophyllotoxin in mouse bone marrow-derived mast cells | 최한곤 |
| 2020-04 | Dual stimuli-responsive ursolic acid-embedded nanophytoliposome for targeted antitumor therapy | 최한곤 |
| 2007-07 | The effect of 1-furan-2-yl-3-pyridine-2-yl-propenone on pharmacokinetic parameters of warfarin | 최한곤 |
